SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT PURSUANT
TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 9, 2017
RENNOVA HEALTH, INC.
(Exact Name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation)
|(Commission File Number)||(I.R.S. Employer Identification No.)|
|400 S. Australian Avenue, Suite 800, West Palm Beach, Florida||33401|
|(Address of Principal Executive Offices)||(Zip Code)|
|(Registrant’s Telephone Number, Including Area Code)|
|(Former Name or Former Address, if Changed Since Last Report)|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|o||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|o||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|o||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|o||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Item 1.01. Entry into a Material Definitive Agreement
As of February 9, 2017, Rennova Health, Inc. (the “Company”) has received advances aggregating $3,000,000 from Christopher Diamantis, a director of the Company. The advances, along with $454,025 of previously accrued but unpaid interest, are due on demand and bear interest at 10% per annum. The Company has used the advances to pay the purchase price under the previously announced asset purchase agreement to acquire certain assets related to Scott Community Hospital based in Oneida, Tennesee, and for general corporate purposes. As security for such advances, the Company has agreed to give Mr. Diamantis a lien on the acquired assets as well as on all of the shares of capital stock of the subsidiary that purchased the assets. The Company has also agreed to issue Mr. Diamantis warrants to purchase shares of common stock on terms to be negotiated.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
The information disclosed in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|Date: February 15, 2017||RENNOVA HEALTH, INC.|
|By: /s/ Seamus Lagan|
|Chief Executive Officer|
|(principal executive officer)|